Annual report pursuant to Section 13 and 15(d)

Note 23 - Quarterly Financial Data (Unaudited) - Quarterly Financial Data (Details)

v3.22.0.1
Note 23 - Quarterly Financial Data (Unaudited) - Quarterly Financial Data (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Interest income $ 108,954 $ 104,236 $ 102,719 $ 100,396 $ 101,065 $ 96,110 $ 95,080 $ 96,767 $ 416,305 $ 389,022 $ 390,803
Interest expense 7,804 7,916 8,051 8,031 8,984 11,028 11,846 19,127 31,802 50,985 103,158
Net interest income 101,150 96,320 94,668 92,365 92,081 85,082 83,234 77,640 384,503 338,037 287,645
Provision for credit losses 8,451 [1] 5,963 [1] 9,652 [1] 7,451 [1] 6,283 [1] 12,284 [1] 10,283 [1] 13,584 [1] 31,517 42,434 22,638
Net income available to common stockholders $ 53,722 $ 52,499 $ 49,996 $ 51,455 $ 50,949 $ 43,362 $ 40,417 $ 34,778 $ 207,672 $ 169,506 $ 149,180
Net income per common share, basic (in dollars per share) $ 0.99 $ 0.97 $ 0.92 $ 0.95 $ 0.94 $ 0.80 $ 0.75 $ 0.65 $ 3.83 $ 3.15 $ 2.79
Net income per common share, diluted (in dollars per share) $ 0.99 $ 0.96 $ 0.92 $ 0.95 $ 0.94 $ 0.80 $ 0.75 $ 0.64 $ 3.82 $ 3.13 $ 2.76
[1] The first three quarters of 2020 were estimated and recorded under the incurred loss methodology and not restated for the adoption of ASC 326. The Company elected to delay the adoption of CECL as allowed under the CARES Act.